"The company has committed to filing its first European Medicines Agency regulatory submission in the second half of next year, using data from three studies of EPP patients."
Well, is it now the 2nd half of next year???? Either that's a journalist mistake or we could be in for a filing even later than Q2 2011? 2nd half is Q3 or Q4.
http://www.biotechnologynews.net/storyview.asp?storyid=1139595
Jeesh...
oh dear...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.95 |
Change
-0.210(1.39%) |
Mkt cap ! $752.6M | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.20 | $14.81 | $536.2K | 35.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 82 | $14.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.96 | 164 | 7 |
View Market Depth
| Last trade - 13.04pm 18/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |